Table of Contents

1 Report Overview

• 1.1 Research Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Biomarkers Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Biomarker of Exposure
  • 1.3.3 Biomarker of Diseases
• 1.4 Market Segment by Application
  • 1.4.1 Global Biomarkers Market Share by Application (2019-2025)
  • 1.4.2 Risk Assessment
  • 1.4.3 Development of Molecular Diagnostic
  • 1.4.4 Disease Diagnosis
  • 1.4.5 Drug Discovery and Development
  • 1.4.6 Drug Formulation
  • 1.4.7 Forensic Application
  • 1.4.8 Others (DNA Fingerprinting and Others)
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Production and Capacity Analysis
  • 2.1.1 Global Biomarkers Production Value 2014-2025
  • 2.1.2 Global Biomarkers Production 2014-2025
  • 2.1.3 Global Biomarkers Capacity 2014-2025
  • 2.1.4 Global Biomarkers Marketing Pricing and Trends
• 2.2 Key Producers Growth Rate (CAGR) 2019-2025
  • 2.2.1 Global Biomarkers Market Size CAGR of Key Regions
  • 2.2.2 Global Biomarkers Market Share of Key Regions
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Capacity and Production by Manufacturers
  • 3.1.1 Global Biomarkers Capacity by Manufacturers
  • 3.1.2 Global Biomarkers Production by Manufacturers
• 3.2 Revenue by Manufacturers
  • 3.2.1 Biomarkers Revenue by Manufacturers (2014-2019)
  • 3.2.2 Biomarkers Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Biomarkers Market Concentration Ratio (CR5 and HHI)
• 3.3 Biomarkers Price by Manufacturers
• 3.4 Key Manufacturers Biomarkers Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Biomarkers Market
• 3.6 Key Manufacturers Biomarkers Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Production and Production Value for Each Type
  • 4.1.1 Biomarker of Exposure Production and Production Value (2014-2019)
  • 4.1.2 Biomarker of Diseases Production and Production Value (2014-2019)
• 4.2 Global Biomarkers Production Market Share by Type
• 4.3 Global Biomarkers Production Value Market Share by Type
• 4.4 Biomarkers Ex-factory Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Biomarkers Consumption by Application

6 Production by Regions

• 6.1 Global Biomarkers Production (History Data) by Regions 2014-2019
• 6.2 Global Biomarkers Production Value (History Data) by Regions
• 6.3 United States
  • 6.3.1 United States Biomarkers Production Growth Rate 2014-2019
  • 6.3.2 United States Biomarkers Production Value Growth Rate 2014-2019
  • 6.3.3 Key Players in United States
  • 6.3.4 United States Biomarkers Import & Export
• 6.4 European Union
  • 6.4.1 European Union Biomarkers Production Growth Rate 2014-2019
  • 6.4.2 European Union Biomarkers Production Value Growth Rate 2014-2019
  • 6.4.3 Key Players in European Union
  • 6.4.4 European Union Biomarkers Import & Export
• 6.5 China
  • 6.5.1 China Biomarkers Production Growth Rate 2014-2019
  • 6.5.2 China Biomarkers Production Value Growth Rate 2014-2019
  • 6.5.3 Key Players in China
  • 6.5.4 China Biomarkers Import & Export
• 6.6 Rest of World
  • 6.6.1 Japan
  • 6.6.2 Korea
  • 6.6.3 India
  • 6.6.4 Southeast Asia

7 Biomarkers Consumption by Regions

• 7.1 Global Biomarkers Consumption (History Data) by Regions
• 7.2 United States
  • 7.2.1 United States Biomarkers Consumption by Type
  • 7.2.2 United States Biomarkers Consumption by Application
• 7.3 European Union
  • 7.3.1 European Union Biomarkers Consumption by Type
  • 7.3.2 European Union Biomarkers Consumption by Application
• 7.4 China
  • 7.4.1 China Biomarkers Consumption by Type
  • 7.4.2 China Biomarkers Consumption by Application
• 7.5 Rest of World
  • 7.5.1 Rest of World Biomarkers Consumption by Type
  • 7.5.2 Rest of World Biomarkers Consumption by Application
  • 7.5.1 Japan
  • 7.5.2 Korea
  • 7.5.3 India
  • 7.5.4 Southeast Asia

8 Company Profiles

• 8.1 Abbott Laboratories
  • 8.1.1 Abbott Laboratories Company Details
  • 8.1.2 Company Description and Business Overview
  • 8.1.3 Production and Revenue of Biomarkers
  • 8.1.4 Biomarkers Product Introduction
  • 8.1.5 Abbott Laboratories Recent Development
• 8.2 Agilent Technologies
  • 8.2.1 Agilent Technologies Company Details
  • 8.2.2 Company Description and Business Overview
  • 8.2.3 Production and Revenue of Biomarkers
  • 8.2.4 Biomarkers Product Introduction
  • 8.2.5 Agilent Technologies Recent Development
• 8.3 Aushon Biosystem
  • 8.3.1 Aushon Biosystem Company Details
  • 8.3.2 Company Description and Business Overview
  • 8.3.3 Production and Revenue of Biomarkers
  • 8.3.4 Biomarkers Product Introduction
  • 8.3.5 Aushon Biosystem Recent Development
• 8.4 Bio-Rad Laboratories
  • 8.4.1 Bio-Rad Laboratories Company Details
  • 8.4.2 Company Description and Business Overview
  • 8.4.3 Production and Revenue of Biomarkers
  • 8.4.4 Biomarkers Product Introduction
  • 8.4.5 Bio-Rad Laboratories Recent Development
• 8.5 Eisai
  • 8.5.1 Eisai Company Details
  • 8.5.2 Company Description and Business Overview
  • 8.5.3 Production and Revenue of Biomarkers
  • 8.5.4 Biomarkers Product Introduction
  • 8.5.5 Eisai Recent Development
• 8.6 Epistem
  • 8.6.1 Epistem Company Details
  • 8.6.2 Company Description and Business Overview
  • 8.6.3 Production and Revenue of Biomarkers
  • 8.6.4 Biomarkers Product Introduction
  • 8.6.5 Epistem Recent Development
• 8.7 Ge Healthcare
  • 8.7.1 Ge Healthcare Company Details
  • 8.7.2 Company Description and Business Overview
  • 8.7.3 Production and Revenue of Biomarkers
  • 8.7.4 Biomarkers Product Introduction
  • 8.7.5 Ge Healthcare Recent Development
• 8.8 Roche Diagnostics
  • 8.8.1 Roche Diagnostics Company Details
  • 8.8.2 Company Description and Business Overview
  • 8.8.3 Production and Revenue of Biomarkers
  • 8.8.4 Biomarkers Product Introduction
  • 8.8.5 Roche Diagnostics Recent Development
• 8.9 Siemens
  • 8.9.1 Siemens Company Details
  • 8.9.2 Company Description and Business Overview
  • 8.9.3 Production and Revenue of Biomarkers
  • 8.9.4 Biomarkers Product Introduction
  • 8.9.5 Siemens Recent Development
• 8.10 Thermo Fisher Scientific
  • 8.10.1 Thermo Fisher Scientific Company Details
  • 8.10.2 Company Description and Business Overview
  • 8.10.3 Production and Revenue of Biomarkers
  • 8.10.4 Biomarkers Product Introduction
  • 8.10.5 Thermo Fisher Scientific Recent Development

9 Market Forecast

• 9.1 Global Market Size Forecast
  • 9.1.1 Global Biomarkers Capacity, Production Forecast 2019-2025
  • 9.1.2 Global Biomarkers Production Value Forecast 2019-2025
• 9.2 Market Forecast by Regions
  • 9.2.1 Global Biomarkers Production and Value Forecast by Regions 2019-2025
  • 9.2.2 Global Biomarkers Consumption Forecast by Regions 2019-2025
• 9.3 United States
  • 9.3.1 Production and Value Forecast in United States
  • 9.3.2 Consumption Forecast in United States
• 9.4 European Union
  • 9.4.1 Production and Value Forecast in European Union
  • 9.4.2 Consumption Forecast in European Union
• 9.5 China
  • 9.5.1 Production and Value Forecast in China
  • 9.5.2 Consumption Forecast in China
• 9.6 Rest of World
  • 9.6.1 Japan
  • 9.6.2 Korea
  • 9.6.3 India
  • 9.6.4 Southeast Asia
• 9.7 Forecast by Type
  • 9.7.1 Global Biomarkers Production Forecast by Type
  • 9.7.2 Global Biomarkers Production Value Forecast by Type
• 9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis

• 10.1 Value Chain Analysis
• 10.2 Sales Channels Analysis
  • 10.2.1 Biomarkers Sales Channels
  • 10.2.2 Biomarkers Distributors
• 10.3 Biomarkers Customers

11 Opportunities & Challenges, Threat and Affecting Factors

• 11.1 Market Opportunities
• 11.2 Market Challenges
• 11.3 Porter's Five Forces Analysis

12 Key Findings

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details

A biomarker, or biological marker is a measurable indicator of some biological state or condition. Biomarkers are often measured and evaluated to examine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers are used in many scientific fields.
The demands of diagnostic markets are increasing. Where conventional diagnostic tools were focused on producing accurate and consistent results, today’s market demand extend to early diagnosis with accurate and consistent results. There are significant challenges in presenting accurate results in the early stage of diseases, especially in case of cancer.
In 2019, the market size of Biomarkers is 11200 million US$ and it will reach 35400 million US$ in 2025, growing at a CAGR of 15.4% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biomarkers.

This report studies the global market size of Biomarkers, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Biomarkers production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Abbott Laboratories
Agilent Technologies
Aushon Biosystem
Bio-Rad Laboratories
Eisai
Epistem
Ge Healthcare
Roche Diagnostics
Siemens
Thermo Fisher Scientific

Market Segment by Product Type
Biomarker of Exposure
Biomarker of Diseases

Market Segment by Application
Risk Assessment
Development of Molecular Diagnostic
Disease Diagnosis
Drug Discovery and Development
Drug Formulation
Forensic Application
Others (DNA Fingerprinting and Others)

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Biomarkers status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Biomarkers manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Biomarkers are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025